The combination of rituximab and cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) is the standard first-line treatment regimen in patients with CD20 + diffuse large B-cell lymphom...
No takes yet. Share an insight, caveat, or question.
Walter et al. (2012) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: